BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND WIF1, WIF-1, 11197, ENSG00000156076
54 results:

  • 1. Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC.
    Simiene J; Dabkeviciene D; Stanciute D; Prokarenkaite R; Jablonskiene V; Askinis R; Normantaite K; Cicenas S; Suziedelis K
    BMC Cancer; 2023 Sep; 23(1):857. PubMed ID: 37697308
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction.
    Kim MJ; Min Y; Jeong SK; Son J; Kim JY; Lee JS; Kim DH; Lee JS; Chun E; Lee KY
    Cell Death Dis; 2022 Apr; 13(4):348. PubMed ID: 35422093
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-Analysis.
    Vandenhoeck J; van Meerbeeck JP; Fransen E; Raskin J; Van Camp G; Op de Beeck K; Lamote K
    J Thorac Oncol; 2021 Sep; 16(9):1461-1478. PubMed ID: 34082107
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The status of wif1 methylation in cell-free DNA is associated with the insusceptibility for gefitinib in the treatment of lung cancer.
    Shen Z; Chen C; Sun J; Huang J; Liu S
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2239-2248. PubMed ID: 34037837
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (wif1) axis.
    Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
    Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells.
    Jou YC; Wang SC; Dai YC; Chen SY; Shen CH; Lee YR; Chen LC; Liu YW
    Oncol Rep; 2019 Sep; 42(3):1005-1016. PubMed ID: 31322264
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Methylation analysis for multiple gene promoters in non-small cell lung cancers in high indoor air pollution region in China.
    Huang X; Wu C; Fu Y; Guo L; Kong X; Cai H
    Bull Cancer; 2018 Sep; 105(9):746-754. PubMed ID: 30126609
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Triptolide exhibits antitumor effects by reversing hypermethylation of WIF‑1 in lung cancer cells.
    Mao X; Tong J; Wang Y; Zhu Z; Yin Y; Wang Y
    Mol Med Rep; 2018 Sep; 18(3):3041-3049. PubMed ID: 30015908
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Triptolide inhibits Wnt signaling in NSCLC through upregulation of multiple Wnt inhibitory factors via epigenetic modifications to Histone H3.
    Nardi I; Reno T; Yun X; Sztain T; Wang J; Dai H; Zheng L; Shen B; Kim J; Raz D
    Int J Cancer; 2018 Nov; 143(10):2470-2478. PubMed ID: 30006924
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Promoter methylation of WNT inhibitory factor-1 may be associated with the pathogenesis of multiple human tumors.
    Zhou Y; Li Z; Ding Y; Zhang P; Wang J; Zhang J; Wang H
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S381-S387. PubMed ID: 29970693
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
    Luo X; Ye S; Jiang Q; Gong Y; Yuan Y; Hu X; Su X; Zhu W
    Int J Oncol; 2018 Aug; 53(2):904-914. PubMed ID: 29916529
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Tumor Suppressive Role of ARHGAP17 in Colon cancer Through Wnt/β-Catenin Signaling.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Physiol Biochem; 2018; 46(5):2138-2148. PubMed ID: 29730655
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.
    Bachet JB; Bouché O; Taieb J; Dubreuil O; Garcia ML; Meurisse A; Normand C; Gornet JM; Artru P; Louafi S; Bonnetain F; Thirot-Bidault A; Baumgaertner I; Coriat R; Tougeron D; Lecomte T; Mary F; Aparicio T; Marthey L; Taly V; Blons H; Vernerey D; Laurent-Puig P
    Ann Oncol; 2018 May; 29(5):1211-1219. PubMed ID: 29438522
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.
    Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L
    Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer.
    Liu S; Chen X; Chen R; Wang J; Zhu G; Jiang J; Wang H; Duan S; Huang J
    Oncotarget; 2017 May; 8(22):36354-36367. PubMed ID: 28422739
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer: A systematic meta-analysis.
    Zheng Y; Li X; Jiang Y; Xu Y; Song B; Zhou Q; Liang X; Yang X
    Medicine (Baltimore); 2016 Dec; 95(49):e5433. PubMed ID: 27930522
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinicopathological significance of wif1 hypermethylation in NSCLC, a meta-analysis and literature review.
    Guo H; Zhou S; Tan L; Wu X; Wu Z; Ran R
    Oncotarget; 2017 Jan; 8(2):2550-2557. PubMed ID: 27911280
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. wif-1 and Ihh Expression and Clinical Significance in Patients With lung Squamous Cell Carcinoma and Adenocarcinoma.
    Zhang Y; Hu C
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):454-461. PubMed ID: 27801732
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer.
    Reno TA; Tong SW; Wu J; Fidler JM; Nelson R; Kim JY; Raz DJ
    BMC Cancer; 2016 Jul; 16():439. PubMed ID: 27400883
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.